Back

Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Antiplatelet therapy Anticoagulants ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Daniele Errigo

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

4 More presentations in this session

Presentation thumbnail
Doctor I. Lianos (London, GB)
Abstract Slides
Presentation thumbnail
Doctor J. Li (Beijing, CN)
Abstract
Presentation thumbnail
Doctor D. Cosmi (Perugia, IT)
Abstract Slides
Presentation thumbnail
Assistant Professor F. Ricci (Chieti, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Antiplatelet therapy

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Congress Presentation
Direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis in cancer-related surgeries: a meta-analysis of efficacy and safety outcomes
31 August 2025
thumbnail
Congress Presentation
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
26 August 2022
thumbnail
Congress Presentation
Intracoronary thrombolysis facilitated primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources